Form 424B3 - Prospectus [Rule 424(b)(3)]
09 11월 2023 - 3:45AM
Edgar (US Regulatory)
Filed
Pursuant to Rule 424(b)(3)
Registration
No. 333-211921
Prospectus
Supplement No. 1 to Reoffer Prospectus
of
Surge
Components Inc.
Up
to 1,159,899 Shares of Common Stock under the 2010 and 2015 Equity Incentive Plans
This
Prospectus Supplement, dated November 8, 2023 (this “Supplement”), supplements the reoffer prospectus filed as part
of the Registration Statement on Form S-8 filed by Surge Components, Inc., (the “Company”,
“us”, “our” or “we”) with the Securities and Exchange Commission (the
“SEC”) on June 8, 2016 (the “Prospectus”), relating to the resale of common stock, par value $ 0. 001
per share (the “Common Stock”), of the Company which may be offered and sold from time to time by certain of our executive
officers and directors (the “Selling Stockholders”) who may be deemed “affiliates” of the Company
as defined in Rule 405 under the Securities Act of 1933, as amended (the “Securities Act”), who have acquired or will
acquire such shares in connection with the exercise of stock options granted, and with stock or other awards made, and with the purchase
of stock under our 2010 Stock Incentive Plan, which we refer to herein as the 2010 Plan, and under our 2015 Equity Incentive Plan, which
we refer to herein as the 2015 Plan, and which we refer to together with the 2010 Plan (the “Plans”). This Supplement
covers 388,179 shares of Common Stock (the “Shares”) including (i) shares of Common Stock (inclusive of shares purchased
pursuant to the Plans) and , (ii) shares issuable upon exercise of options granted under the that are owned by or may in the future be
issued to the Selling Stockholders.
You
should read this Supplement in conjunction with the Prospectus. This Supplement is qualified by reference to the Prospectus, except to
the extent the information in this Supplement supersedes the information contained in the Prospectus.
Our
Common Stock is quoted on the OTC Markets under the symbol “SPRS” On November 8, 2023, the closing sales price of our Common
Stock was $2.74 per share.
The
Shares may be offered from time to time by any or all of the Selling Stockholders through ordinary brokerage transactions, in negotiated
transactions or in other transactions, at such prices as such Selling Stockholder may determine, which may relate to market prices prevailing
at the time of sale or be a negotiated price. See “Plan of Distribution” in the Prospectus. Sales may be made through
brokers or to dealers, who are expected to receive customary commissions or discounts. We
will not control or determine the price at which a Selling Stockholder decides to sell its shares. Brokers or dealers effecting transactions
in these shares should confirm that the shares are registered under applicable state law or that an exemption from registration is available.
The
Selling Stockholders and participating brokers and dealers may be deemed to be “underwriters” within the meaning of the Securities
Act, in which event any profit on the sale of shares of those Selling Stockholders and any commissions or discounts received by those
brokers or dealers may be deemed to be underwriting compensation under the Securities Act.
You
should carefully read and consider the risk factors under Item 1A beginning on page 9 of our Annual Report on Form 10-K for the
year ended November 30, 2022 for risks relating to investment in the Company’s securities.
Neither
the SEC nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of
the Prospectus or this Supplement. Any representation to the contrary is a criminal offense.
The
information set forth under the caption “Selling Stockholders” in the Prospectus is amended and restated in its entirety
as set forth below and is provided for the primary purpose of updating the table of selling stockholders contained in the Prospectus.
The
date of this Supplement is November 8, 2023
SELLING
STOCKHOLDERS
The
following table sets forth, as of November 6, 2023, (a) the name and position or positions with the Company of each Selling Stockholder;
(b) the aggregate of (i) the number of shares of Common Stock held by each Selling Stockholder as of the date of this Supplement and
(ii) the number of shares issuable upon exercise of options and vesting of restricted stock units granted to each Selling Stockholder
under the Plans, as supplemented by this Supplement, for resale by each Selling Stockholder as of the date of this Supplement; (c) the
number of shares of Common Stock that each Selling Stockholder may offer for sale from time to time pursuant to the Prospectus, as supplemented
by this Supplement, whether or not such Selling Stockholder has a present intention to do so; and (d) the number of shares of Common
Stock to be beneficially owned by each Selling Stockholder following the sale of all shares that may be so offered pursuant to the Prospectus,
as supplemented by this Supplement, assuming no other change in ownership of Common Stock by such Selling Stockholder after the date
of this Supplement. Unless otherwise indicated, beneficial ownership is direct and the person indicated has sole voting and investment
power.
The
selling stockholders are our current and former directors and officers (or any of their respective assigns) who have acquired or may
acquire in the future shares of our common stock under the Plans. The selling stockholders may, from time to time, resell all or a portion
of the shares of our common stock covered by this reoffer prospectus. There is no assurance that any of the selling stockholders will
sell any or all of the shares offered by them under this reoffer prospectus. The address for each of the selling stockholders listed
below is c/o Surge Components Inc., 95 Jefryn Boulevard, Deer Park, New York, 11729. Any changed information will be set forth in an
amendment to the registration statement or supplement to this reoffer prospectus, to the extent required by law.
Name | |
Position | |
Number of
Shares
Owned
Prior to
the
Offering(1) | | |
Number of
Shares
Included
in this Offering(2) | | |
Number of
Shares to
be Owned
After
Completion
of the
Offering(3) | | |
Percentage
of Shares
to be
Owned
After
Completion
of the Offering(4) | |
Ira Levy | |
CEO and Director | |
| 1,365,202 | | |
| 107,341 | | |
| 1,257,861 | | |
| 22.70 | % |
Steven J. Lubman | |
Vice President and Director | |
| 1,111,952 | | |
| 100,838 | | |
| 1,011,114 | | |
| 18.25 | % |
Lawrence Chariton | |
Director | |
| 192,573 | | |
| 35,000 | | |
| 157,573 | | |
| 2.84 | % |
Alan Plafker | |
Director | |
| 46,334 | | |
| 20,000 | | |
| 26,334 | | |
| * | % |
Gary Jacobs | |
Director | |
| 182,000 | | |
| 55,000 | | |
| 127,000 | | |
| 2.29 | % |
Peter Levy | |
Director | |
| 35,000 | | |
| 35,000 | | |
| 0 | | |
| * | % |
Martin Novick | |
Director | |
| 35,000 | | |
| 35,000 | | |
| 0 | | |
| * | % |
|
* |
Less
than 1%. |
|
|
|
|
(1) |
The shares owned by a person
include shares owned by the individual as well as shares granted, or exercisable upon the exercise of options granted to the selling
stockholder under the Plans, whether or not such options vest or become exercisable (as applicable) within 60 days of the date of
this reoffer prospectus. |
|
(2) |
The amounts for each selling
stockholder assume full vesting and exercise of all outstanding options to purchase common stock held by such selling stockholder. |
|
(3) |
Assumes that all shares
offered hereby are sold but no other securities held by selling stockholders are sold. |
|
(4) |
This table has been prepared
based on 5,541,342 shares of common stock outstanding as of November 2023. |
Surge Components (PK) (USOTC:SPRS)
과거 데이터 주식 차트
부터 11월(11) 2024 으로 12월(12) 2024
Surge Components (PK) (USOTC:SPRS)
과거 데이터 주식 차트
부터 12월(12) 2023 으로 12월(12) 2024